This study is looking at a specific treatment approach for women aged 45 or older with a certain type of breast cancer (clinical T1-2N0 ER+ invasive breast cancer) that has spread to the lymph nodes (axillary nodal disease). You cannot have HER2+ or ER- breast cancer to join. The study will involve breast surgery (either a lumpectomy or mastectomy) along with TAD/SNB (Targeted Axillary Dissection/Sentinel Node Biopsy) and then radiation therapy. The main goal is to see how many patients experience the cancer returning in the region (regional recurrence) after 5 years. The study plans to enroll 45 participants, but its current status is unclear.

Study design

This is a single-arm Phase II clinical trial, meaning all participants will receive the same treatment. It plans to enroll 45 participants.

What's involved

You would undergo breast surgery (lumpectomy or mastectomy) with TAD/SNB, followed by adjuvant radiation therapy. Patient, tumor, and treatment data will be documented.

Compensation

Not stated in the trial record.

Follow-up

The study will measure regional recurrence rates at 5 years, suggesting follow-up for at least that long.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.